Trial Profile
Efficacy and safety of everolimus and exemestane in treatment of advanced breast cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms BRAWO
- 06 Jun 2017 Updated results of 3rd interim analysis, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 02 Jun 2017 Results (data cut-off 18 Oct 2016; n=1345) of third interim analysis, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 12 Dec 2015 3rd Interim results (n=1300) presented at the 38th Annual San Antonio Breast Cancer Symposium